Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
DAVID MARCUS: Trump’s base trusts him to play...
Trump weighs striking Iranian nuclear facilities: ‘I may...
GOP says Dems admit ‘guilt’ in Biden health...
Poll position: Where Trump stands in the eyes...
Ilhan Omar claims no one has ‘attacked Americans,’...
‘Squad’ members, GOP lawmaker join forces to reject...
Vance defends Gabbard as ‘critical part’ of Trump...
Trump downplays signs of MAGA unrest over possible...
‘Instincts for restraint’: Senate divided over who gets...
Top Trump ally predicts Senate will blow past...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
Brian Leni: Latest Mining Stock Wins and How I’m Deploying Cash Now
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

White House OPM orders all DEI offices to...

January 22, 2025

Trump isn’t the first US commander in chief...

March 3, 2025

House Freedom Caucus to draw battle lines on...

January 16, 2025

Rubio says ‘no choice’ but to bring USAID...

February 4, 2025

Israel reimposes blockade of northern Gaza, including capital...

March 20, 2025

Judicial pushback on Trump ‘hurting American people,’ says...

February 25, 2025

China exerts new restrictions on exports of minerals...

September 17, 2024

Top political gaffes of 2024

December 28, 2024

US still has no UN ambassador as world...

June 17, 2025

All about the Dons: House GOP bill would...

March 3, 2025

Recent Posts

  • DAVID MARCUS: Trump’s base trusts him to play strong hand in Iran
  • Trump weighs striking Iranian nuclear facilities: ‘I may do it, I may not do it’
  • GOP says Dems admit ‘guilt’ in Biden health cover-up by boycotting Senate hearing on ‘constitutional scandal’
  • Poll position: Where Trump stands in the eyes of Americans five months into his second presidency
  • Ilhan Omar claims no one has ‘attacked Americans,’ but Iran’s deadly history tells different story

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (792)
    • Investing (2,350)
    • Politics (2,910)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.